Is BusterBob painting signs? He hasn’t said this company is a scam in at least 48 hours?
I suspect enrollment will be complete in 1-2 weeks. Based on the timeline, it looks like they may have paused enrollment for the safety look by DMC. In two weeks enrollement moved more than 20%.
Wake me up in June! Pool party at my place!
Yeah, so shorts and spammers seem to be running free and loose here today...
3000 shares is not executive dumping. Sometimes people take a little profit along the way - especially when they have more options...
I’ve sold many times more than that and still have a giant pile of shares (0.37 avg...love this stock!)
Buster Bob,
How is IPIX whipping up the media? They give press releases like once every three months on a potentially ground breaking/game changing therapeutic...
If anything, their PR department leaves quite a bit to be desired. If Brilacidin proves effective, it will essentially be a surprise to the market and the mainstream media...
Buster Bob,
Did you figure out that nitric vs nitrous oxide thing yet?
Chemistry is tough. Especially basic high school/undergrad chemistry...
What’s the source of the Merck rumor?
Buster Bob is back! I was worried something happened to him...
Actually, Bob, the company has been a pretty terrible source of information...
I tend to read primary literature. I’m also trained to (one of those medical guys).
Did you go back and read about the difference between nitric and nitrous oxide (seriously, I’m going to dine out on this one for months!)
It’s interesting that out of all the combo therapy studies announced, they are continuing with one mono therapy study (primary t-cell lymphoma) because “there are no good agents available” to treat in combo...
Not just bullish as an investor - this is an exciting time to watch cancer therapies evolve!
Predictions:
April 28 - 622 data readout, multiple combo therapy stage 3 trials announced.
Price goes to 20-50$ a share.
May 1 - buyout offer.
May 2 - I pay off my mortgage.
BusterBob
You know there’s a difference between Nitric Oxide (NO) (the vasodilator/flow impedance reducer) and Nitrous Oxide (N2O) (the gas you inhale before you post on this board)...
Glad we are reading advice on biotech from someone who failed undergrad biochemistry...
Vijay - remdesevir is not anywhere close to 99% effective. Where did you get this number. It has shown no mortality benefit, but does show a decrease in hospital length of stay.
Right now remdesevir is just the best thing we have to use - anything with mortality benefit will essentially replace remdesevir.
Likely clear benefit will be combination therapy.
Whether Brilacidin shows that benefit will only be apparent when they unblind the data. The suspicion is that they got that signal early on... hence adding sites and the fda interest...